Funding Rounds
Senisca

Senisca Seed (2024, $4M)

Senisca

RNA-based senotherapeutics developer to treat age-related disease.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $4.71M

Investors